Dorsey Wright & Associates Albireo Pharma, Inc. Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 31, 2019
SELL
$20.0 - $31.88 $6,840 - $10,902
-342 Closed
0 $0
Q2 2019

Jul 02, 2019
BUY
$30.67 - $37.86 $10,489 - $12,948
342 New
342 $11,000

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email